UroGen Pharma Ltd. (URGN) Balance Sheet
As of 2026-06-30 (10-Q), UroGen Pharma Ltd. (URGN) reported total assets of $252.6M, total liabilities of $385.0M and shareholders' equity of -$132.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $79.1M. Long-term debt: $188.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
URGNUroGen Pharma Ltd.Follow URGN — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 21.4 | 37.0 | 101.3 | 49.7 | 52.9 | 44.4 | 55.4 | 95.0 | 172.0 | 110.7 | 79.1 | |
| Short-term investments | — | 36.0 | — | 97.4 | 49.2 | 44.8 | 44.6 | 42.0 | 64.7 | 9.7 | 28.8 | |
| Receivables | 0.1 | — | — | — | 7.0 | 11.7 | 12.7 | 15.4 | 20.3 | 33.1 | 88.8 | |
| Inventory | 0.1 | 0.3 | — | — | 2.0 | 4.8 | 4.3 | 5.7 | 9.2 | 16.5 | 24.6 | |
| Current assets | 22.0 | 74.5 | 102.2 | 148.6 | 115.6 | 114.4 | 128.9 | 169.2 | 276.1 | 186.0 | 235.4 | |
| Total assets | 23.1 | 75.6 | 103.6 | 202.4 | 122.0 | 119.7 | 135.6 | 178.3 | 285.7 | 200.5 | 252.6 | |
| Current liabilities | 3.1 | 7.0 | 13.5 | 19.5 | 21.4 | 22.4 | 23.9 | 31.2 | 45.9 | 46.4 | 61.9 | |
| Long-term debt | — | — | — | — | — | 0.0 | 97.5 | 98.6 | 121.7 | 122.2 | 188.7 | |
| Total liabilities | 6.7 | 7.0 | 13.5 | 22.1 | 25.7 | 111.3 | 225.0 | 243.5 | 294.5 | 305.9 | 385.0 | |
| Shareholders' equity | 16.3 | 68.5 | 90.1 | 180.3 | 96.4 | 8.4 | -89.4 | -65.2 | -8.8 | -105.5 | -132.4 |
USD millions · SEC XBRL
UroGen Pharma Ltd. — questions
- How much cash does UroGen Pharma Ltd. have?
- $79.1M in cash and cash equivalents as of 2026-06-30.
- How much debt does UroGen Pharma Ltd. have?
- $188.7M of long-term debt as of 2026-06-30.
- What are UroGen Pharma Ltd.'s total assets?
- $252.6M as of 2026-06-30.
- What is UroGen Pharma Ltd.'s shareholders' equity?
- -$132.4M as of 2026-06-30.
Every figure on this page comes from UroGen Pharma Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.